跳至主要内容
临床试验/TCTR20190830005
TCTR20190830005尚未招募2 期

The effect of branched-chain amino acid granules to innate immunity in decompensated cirrhosis, A randomized controlled trial

Faculty of Medicine, Prince of Songkla University0 个研究点目标入组 72 人开始时间: 2019年8月30日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • - Age between 18 to 70 years old.
  • - Diagnosed with cirrhosis either by imaging or histopathology
  • - Child-Pugh score ≥ 7 points
  • - History or currently documented ascites by imaging
  • - Agree to sign inform consent

排除标准

  • - Previous hospitalization due to infection within 3 months
  • - Any active malignancies
  • - life expectancy < 9 months
  • - Stop alcohol drinking < 6 months
  • - On steroid or Immunosuppressive drugs
  • - Uncontrolled diabetes mellitus defined by HbA1c ≥ 8 %
  • - HIV infection
  • - eGFR < 30 ml/min/1.73m2
  • - History of taking branched-chain amino acid
  • - Pregnancy or lactation
  • - MELD score ≥ 20 points

研究者

发起方
Faculty of Medicine&#44; Prince of Songkla University

相似试验